ZFIN Fish: gper1^zf2223/zf2223

ZFIN ID: ZDB-FISH-200810-5

ZFIN ID: ZDB-FISH-200810-5

Fish name:	gper1^{zf2223/zf2223}
Genotype:	gper1^{zf2223/zf2223}
Targeting Reagent:	none

HUMAN DISEASE MODELED by gper1^{zf2223/zf2223}
No data available

GENE EXPRESSION
Gene expression in gper1^{zf2223/zf2223}

RNA expression

Expressed Gene	Structure	Conditions	Figures
fabp10a	hepatocyte	control	Fig. 4 from Chaturantabut et al., 2019
	hepatocyte	chemical treatment by environment: effector	Fig. 4 from Chaturantabut et al., 2019
gper1	(not) whole organism	standard conditions	Fig. S3 from Chaturantabut et al., 2019

Protein expression

Antibody	Antigen Genes	Structure	Conditions	Figures
Ab1-rps6		whole organism	chemical treatment by environment: 17beta-estradiol	Fig. 4 from Chaturantabut et al., 2019
Ab5-akt		male organism liver whole organism	chemical treatment by environment: effector	Fig. 4, Fig. 6 from Chaturantabut et al., 2019
Ab5-akt		whole organism	control	Fig. 4 from Chaturantabut et al., 2019
Ab3-gper1	gper1	(not) whole organism	standard conditions	Fig. S3 from Chaturantabut et al., 2019

Reporter gene expression No data available

PHENOTYPE
Phenotype in gper1^{zf2223/zf2223}

Phenotype	Conditions	Figures
female organism liver increased mass, abnormal	chemical treatment by environment: 17beta-estradiol	Fig. 6 from Chaturantabut et al., 2019
female organism liver increased weight, abnormal	chemical treatment by environment: 17beta-estradiol	Fig. 6 from Chaturantabut et al., 2019
liver decreased size, abnormal	control	Fig. 4 from Chaturantabut et al., 2019
liver decreased size, abnormal	chemical treatment by environment: MK-2206	Fig. 4 from Chaturantabut et al., 2019
liver decreased size, abnormal	chemical treatment by environment: MK-2206, chemical treatment by environment: 17beta-estradiol	Fig. 4 from Chaturantabut et al., 2019
liver decreased size, abnormal	chemical treatment by environment: G-1	Fig. 4 from Chaturantabut et al., 2019
liver decreased size, abnormal	chemical treatment by environment: 17beta-estradiol	Fig. 4 from Chaturantabut et al., 2019
liver neoplastic, ameliorated	chemical treatment by environment: 7,12-dimethyltetraphene	Fig. 7 from Chaturantabut et al., 2019
liver size, ameliorated	chemical treatment by environment: effector	Fig. 4 from Chaturantabut et al., 2019
male organism liver ab5-akt labeling amount, ameliorated	chemical treatment by environment: 17beta-estradiol	Fig. 6 from Chaturantabut et al., 2019
male organism liver increased mass, ameliorated	chemical treatment by environment: 17beta-estradiol	Fig. 6 from Chaturantabut et al., 2019
male organism liver increased weight, ameliorated	chemical treatment by environment: 17beta-estradiol	Fig. 6 from Chaturantabut et al., 2019
whole organism gper1 expression absent, abnormal	standard conditions	Fig. S3 from Chaturantabut et al., 2019
whole organism ab1-rps6 labeling amount, ameliorated	chemical treatment by environment: 17beta-estradiol	Fig. 4 from Chaturantabut et al., 2019
whole organism ab1-rps6 labeling amount, ameliorated	chemical treatment by environment: G-1	Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling amount, ameliorated	chemical treatment by environment: effector	Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling decreased amount, abnormal	control	Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling decreased amount, abnormal	chemical treatment by environment: MK-2206, chemical treatment by environment: 17beta-estradiol	Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling decreased amount, abnormal	chemical treatment by environment: MK-2206	Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling decreased amount, abnormal	chemical treatment by environment: 17beta-estradiol	Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling increased amount, abnormal	chemical treatment by environment: G-1	Fig. 4 from Chaturantabut et al., 2019

CITATIONS (1)